The latest happenings in the industry, all in one place.
Ergomed plc announced the appointment of Lewis Cameron as Chief Operating Officer and to the Board.
CTI Clinical Trial and Consulting Services has announced the additions of Savannah Doliboa and Nick Finan to the Business Development department and Rochelle Maher to the Regulatory & Scientific Affairs department. They also announced the promotions of Ana Patacão to Executive Director, Real World Evidence & Late Phase, and Brian Johnston to Senior Director, Clinical Project Management.
LaRee Tracy
PHASTAR announced the hiring of LaRee Tracy, PhD, as Director of Biostatistics.
Spaulding Clinical Research has announced that it has named Cassandra Erato Chief Executive Officer.
Syntactx announced that Dorothy Abel has joined the company as Vice President, Regulatory Strategy.
Continuum Clinical has announced Paul Ivsin as the new Vice President of Data and Analytics.
Clinerion and Datametrix partner to deliver Real World Evidence insights from Real World Data from Clinerion’s global hospital network.
In 2019, AG Mednet realized more than 35 percent growth both in revenue and new product sales, and nearly 40 percent growth in average deal-value.
Nebraska Innovation Campus has announced Celerion will move into a space on the campus.
Veeva Systems announced that an increasing number of life sciences companies are adopting applications in the Veeva Vault RIM Suite to streamline regulatory information management.
PHASTAR announced that the company has chosen San Diego as the site for its new U.S. West Coast office.
Novotech has won the Australian-Korean Business Awards 2020 - Award for Excellence, in the category Biotech and Health.
Advanced Clinical has been recognized by ClearlyRated, earning the Best of Staffing Client and Talent Awards for the fifth consecutive year.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia
July 14th 2025Results from the Phase III CAHtalyst show that patients treated with Crenessity for classic congenital adrenal hyperplasia achieved and maintained lower, more physiologic glucocorticoid doses while keeping key adrenal biomarkers at or below baseline levels.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.